About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Arizona | 255 Studies

Clinical Trials MelanomaArizona

Melanoma Clinical Trials in Arizona

Find 255 clinical trials for melanoma near Arizona. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 255 trials

CompletedUV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of MelanomaThis is a randomized, open label study to investigate efficacy and safety of UV1 vaccination in combination with nivolumab and ipilimumab as first line treatment of adult patients…NCT04382664·Phoenix, Arizona and 36 others

PreviousPage 4 of 13Next

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingAssessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsThis is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are…NCT06418204·Fairbanks, Alaska and 466 others

CompletedA Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerThis is a Phase I, multi-center, multiple ascending dose study to evaluate the clinical safety and immune response of IDC-G305 when injected intramuscularly in patients with…NCT02015416·Scottsdale, Arizona and 3 others

RecruitingRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsPhase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with…NCT06814496·Gilbert, Arizona and 2 others

CompletedAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)This is a Phase 1, open-label, dose-escalation trial of avelumab \[antibody targeting programmed death ligand 1 (anti PD-L1)\] with consecutive parallel group expansion in…NCT01772004·Goodyear, Arizona and 73 others

CompletedMinimally Invasive Groin Dissection for MelanomaThe purpose of this this study is to determine if a structured educational training program is successful in teaching surgeons a new operative technique.NCT01500304·Scottsdale, Arizona and 10 others

CompletedAn Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV MelanomaThe purpose of this study is to assess the objective response rate of lenvatinib in previously treated participants with American Joint Committee on Cancer (AJCC) unresectable…NCT01136967·Birmingham, Alabama and 94 others

WithdrawnLow-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic MelanomaThe purpose of this study is to determine response rates by administering low dose cyclophosphamide on day 1, followed by 5 days of outpatient IL2.NCT01833767·Goodyear, Arizona

TerminatedInterleukin-2 in Metastatic MelanomaTo determine whether Interleukin-2 at the dose and schedule will help to increase tumor shrinkageNCT01702896·Goodyear, Arizona

CompletedGSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive MelanomaThis is a two-arm, open-label, randomized Phase III study comparing single agent GSK1120212 to chemotherapy (either dacarbazine or paclitaxel) in subjects with Stage IIIc or Stage…NCT01245062·Tucson, Arizona and 111 others

CompletedA Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid TumorsThis is an open-label, multicenter, multi-dose escalation and dose expansion study in subjects with selected advanced solid tumors (Part A) and advanced metastatic pancreatic…NCT04731467·Scottsdale, Arizona and 17 others

RecruitingMelanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous MelanomaPatients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin.NCT03860883·Mobile, Alabama and 191 others

UnknownRandomized Trial of ATN-224 and Temozolomide in Advanced MelanomaThis is a multicenter, randomized, phase II study to evaluate the safety and efficacy of oral ATN-224 plus temozolomide in patients with advanced melanoma.NCT00383851·Tucson, Arizona and 16 others

TerminatedA Study of ADXS-NEO Expressing Personalized Tumor AntigensThis is a Phase 1, open-label, multicenter study of ADXS-NEO administered alone and in combination with pembrolizumab in participants with select advanced or metastatic solid…NCT03265080·Scottsdale, Arizona and 4 others

CompletedStudy of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant MelanomaThis is a Phase I, open-label, multicenter, pharmacokinetic study of MDX-010 in up to 90 evaluable subjects with surgically unresectable malignant melanoma.NCT00729950·Tucson, Arizona and 3 others

CompletedA Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced MelanomaThis is a Phase III, double-blinded, placebo-controlled, randomized, multicenter study designed to evaluate the efficacy, safety, and pharmacokinetics of atezolizumab +…NCT02908672·Birmingham, Alabama and 109 others

CompletedComparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic MelanomaThe objectives of this study are to determine the safety and activity profile of multiple doses of MDX-010, and to determine the whether the addition of cytotoxic chemotherapy…NCT00050102·Tucson, Arizona and 8 others

SuspendedJSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway MutationsThis is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations…NCT04418167·Phoenix, Arizona and 6 others

Active not recruitingA Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)Stage 1: To select the optimal dose of naporafenib + trametinib to be studied in Stage 2.NCT06346067·Phoenix, Arizona and 58 others

RecruitingA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional…NCT05824975·Scottsdale, Arizona and 10 others

Other Conditions in Arizona

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma